varespladib

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2017
02420092017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Phospholipase A₂s (PLA₂) is a major component of snake venom with diverse pathologic toxicities and, therefore, a potential… (More)
Is this relevant?
2016
2016
Snakebite remains a neglected medical problem of the developing world with up to 125,000 deaths each year despite more than a… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2014
Highly Cited
2014
IMPORTANCE Secretory phospholipase A2 (sPLA2) generates bioactive phospholipid products implicated in atherosclerosis. The sPLA2… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2013
2013
OBJECTIVE Several secreted phospholipases A2 (sPLA2s), including group IIA, III, V, and X, have been linked to the development of… (More)
Is this relevant?
2010
2010
OBJECTIVES The purpose of this study was to investigate the effects of varespladib on cardiovascular biomarkers in acute coronary… (More)
  • table 2
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
BACKGROUND Secretory phospholipase A(2) (sPLA(2)) may play a role in myonecrosis after elective percutaneous coronary… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2009
2009
Secretory phospholipase A2 (sPLA2) activity promotes foam cell formation, increases proinflammatory bioactive lipid levels… (More)
Is this relevant?
2009
2009
BACKGROUND The association of elevated serum levels of secretory phospholipase A2 (sPLA2) in patients with cardiovascular disease… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2009
2009
Varespladib methyl is an oral secretory phospholipase A2 inhibitor that is being developed by Anthera Pharmaceuticals Inc for the… (More)
Is this relevant?
2009
2009
Phase II results of the trials of two phospholipase A2 inhibitors which may be of value in the treatment of atherosclerosis and… (More)
Is this relevant?